FDA Inspection 1022521 — Celltrion Skincure Co., Ltd. (Hanskin)
The FDA completed an inspection of Celltrion Skincure Co., Ltd. (Hanskin) on Jun 2, 2017 in Paju. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 2, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Paju (Korea (the Republic of))